Saliva test may reveal who benefits from psychedelic therapy for depression
NCT ID NCT07345858
First seen Jan 19, 2026 · Last updated May 13, 2026 · Updated 21 times
Summary
This study looks at whether a natural chemical called oxytocin, measured in saliva during a psychedelic therapy session, can help predict how well people with hard-to-treat depression will respond to treatment. Researchers will track 80 adults with major depressive disorder who are already in talk therapy. The goal is to see if changes in oxytocin levels relate to improvements in depressive symptoms and mental flexibility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geneva University Hospitals
Geneva, Switzerland
Conditions
Explore the condition pages connected to this study.